1
Stéphane De Lombaert
DE LOMBAERT Stéphane, LIU Weimin, LO Ho Yin, NEMOTO Peter Allen: INHIBITEURS BENZIMIDAZOLE DE PRODUCTION DE LEUCOTRIÈNES, BENZIMIDAZOLE INHIBITORS OF LEUKOTRIENE PRODUCTION. BOEHRINGER INGELHEIM INTERNATIONAL, DE LOMBAERT Stéphane, LIU Weimin, LO Ho Yin, NEMOTO Peter Allen, MORRIS Michael P, May 10, 2012: WO/2012/061169 (1 worldwide citation)

The present invention relates to compounds of formula (IA), (IB) and (IC) and pharmaceutically acceptable salts thereof, wherein R1-R7 are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of var ...


2
Stéphane De Lombaert
BARTOLOZZI Alessandra, BOSANAC Todd, CHEN Zhidong, DE LOMBAERT Stéphane, HUBER John D, LIU Weimin, LO Ho Yin, LOKE Pui Leng, RIETHER Doris, TYE Heather, WU Lifen, ZINDELL Renee M: INHIBITEURS OXADIAZOLE DE PRODUCTION DE LEUCOTRIÈNES, OXADIAZOLE INHIBITORS OF LEUKOTRIENE PRODUCTION. BOEHRINGER INGELHEIM INTERNATIONAL, BARTOLOZZI Alessandra, BOSANAC Todd, CHEN Zhidong, DE LOMBAERT Stéphane, HUBER John D, LIU Weimin, LO Ho Yin, LOKE Pui Leng, RIETHER Doris, TYE Heather, WU Lifen, ZINDELL Renee M, MORRIS Michael P, March 29, 2012: WO/2012/040137

The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R1-R5 are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases an ...


3
Stéphane De Lombaert
CHEN Zhidong, DE LOMBAERT Stéphane, DINES Jonathon Alan, LIU Weimin, LO Ho Yin, LOKE Pui Leng: INHIBITEURS BENZIMIDAZOLES DE LA PRODUCTION DE LEUCOTRIÈNES, BENZIMIDAZOLE INHIBITORS OF LEUKOTRIENE PRODUCTION. BOEHRINGER INGELHEIM INTERNATIONAL, CHEN Zhidong, DE LOMBAERT Stéphane, DINES Jonathon Alan, LIU Weimin, LO Ho Yin, LOKE Pui Leng, MORRIS Michael P, May 3, 2012: WO/2012/058254

The present invention relates to compounds of formula IA and IB and pharmaceutically acceptable salts thereof, wherein R1-R7 are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various disea ...


4

5
Bosanac Todd, Ginn John David, Hickey Eugene Richard, Kirrane Thomas Martin, Liu Weimin, Prokopowicz Anthony S, Shih Cheng Kon, Snow Roger John, Turner Michael Robert, Wu Frank, Young Erick Richard, Schlyer Sabine K: Rho kinase inhibitors. Boehringer Ingelheim International, Boehringer Ingelheim Pharma & Co Kg, Bosanac Todd, Ginn John David, Hickey Eugene Richard, Kirrane Thomas Martin, Liu Weimin, Prokopowicz Anthony S, Shih Cheng Kon, Snow Roger John, Turner Michael Robert, Wu Frank, Young Erick Richard, Schlyer Sabine K, MORRIS Michael P, March 27, 2008: WO/2008/036540 (21 worldwide citation)

Disclosed are novel substituted 2H-isoquinolin-1-one and 3H-quinazolin-4-one derivatives useful as inhibitors of Rho kinase and for treating a variety of diseases and disorders that are mediated or sustained through the activity of Rho kinase, including cardiovascular diseases, pharmaceutical compos ...


6
Hickey Eugene R, Liu Weimin, Sun Sanxing, Ward Yancey David, Young Erick Richard Roush: Cathepsin s inhibitors. Boehringer Ingelheim Pharmaceuticals, Hickey Eugene R, Liu Weimin, Sun Sanxing, Ward Yancey David, Young Erick Richard Roush, RAYMOND Robert P, September 30, 2004: WO/2004/083182 (11 worldwide citation)

This invention relates to peptidyl compounds of the formulas (I) and (II) active as cathepsin S, a cysteine protease, inhibitors. The compounds are selective, reversible inhibitors of the cathepsin S are therefore useful in the treatment of autoimmune and other diseases. The invention also relates t ...


7

8
Liu Weimin, Hickey Eugene Richard, Cywin Charles Lawrence, Fleck Roman Wolfgang, Spero Denice M, Morwick Tina Marie, Proudfoot John Robert: Substituted tricyclic heterocycles and their uses. Boehringer Ingelheim Pharmaceuticals, Liu Weimin, Hickey Eugene Richard, Cywin Charles Lawrence, Fleck Roman Wolfgang, Spero Denice M, Morwick Tina Marie, Proudfoot John Robert, RAYMOND Robert P, April 21, 2005: WO/2005/035537 (5 worldwide citation)

Disclosed are substituted tricyclic heterocycle compounds of the formulas (I), (II) and (III) shown below, wherein R1, R2, R3 and R4 are described herein, which are active as anti-inflammatory agents. Also disclosed are methods of using and making such compounds.


9
MA Liangping, ZIERA Ariela, SHAHEEN Kamel M, LIU Hang, DENG Zhuorong, LIU Weimin, WALLACE Chris, RAPAPORT Avi, CHEN Zhifeng, HEPLER Edward L, MILLER James M, PRAGADA Ravikumar V, RYU Eun: [fr] PROCÉDÉS ET SYSTÈMES DE DIFFÉRENCIATION DE PAQUETS, [en] METHODS AND SYSTEMS FOR PACKET DIFFERENTIATION. MA Liangping, ZIERA Ariela, SHAHEEN Kamel M, LIU Hang, DENG Zhuorong, LIU Weimin, WALLACE Chris, RAPAPORT Avi, CHEN Zhifeng, HEPLER Edward L, MILLER James M, PRAGADA Ravikumar V, RYU Eun, VID SCALE, ROCCIA Vincent J, February 21, 2013: WO/2013/025534 (4 worldwide citation)

[en] Methods and systems are disclosed facilitate differentiated QoS service for packets within a single packet stream. For example, extended QCI values may be used to differentiate service of video packets associated with different priorities. A flexible representation of QoS requirements/parameter ...


10